Indonesia’s Bio Farma Gains Boost From Germany’s Artes Biotechnology To Expand Vaccines Output
This article was originally published in PharmAsia News
Executive Summary
Bio Farma says new technology will help expand vaccines production and work on a hepatitis B vaccine as the country moves to launch a phased universal health care insurance program next year.